The ERA Registry Annual Report 2023: epidemiology of kidney replacement therapy in Europe, with a focus on age comparisons

Marin W F Hoekstra; Rianne Boenink; Marjolein Bonthuis; Brittany A Boerstra; Megan E Astley; Iris R Montez de Sousa; Nikola Gjorgjievski; Halima Resic; Nicos Mitsides; Kristine Hommel; Rebecca Guidotti; Inmaculada Marín Sánchez; María F Slon-Roblero; Marta Artamendi; Pazit Beckerman; Lukas Buchwinkler; Ryszard Gellert; Viktorija Kuzema; Adrián Okša; Jordi Comas; Line M T J Heylen; Mathilde Lassalle; Sara Hernandez Ramirez; Shalini Santhakumaran; Nurhan Seyahi; Anders Åsberg; Laurent E Weekers; José M Muñoz-Terol; Sara Trujillo-Alemán; Fatime Memeti Smaili; Mai Ots-Rosenberg; Olafur S Indridason; Kirill S Komissarov; Marc A G J Ten Dam; Maria Stendahl; Ana A Galvão; Alberto Ortiz; Vianda S Stel; Anneke Kramer

doi:10.1093/ckj/sfag036

The ERA Registry Annual Report 2023: epidemiology of kidney replacement therapy in Europe, with a focus on age comparisons

Marin W F Hoekstra
, Rianne Boenink (Corresponding Author)
, Marjolein Bonthuis
, Brittany A Boerstra
, Megan E Astley
, Iris R Montez de Sousa
, Nikola Gjorgjievski
, Halima Resic
, Nicos Mitsides
, Kristine Hommel
, Rebecca Guidotti
, Inmaculada Marín Sánchez
, María F Slon-Roblero
, Marta Artamendi
, Pazit Beckerman
, Lukas Buchwinkler
, Ryszard Gellert
, Viktorija Kuzema
, Adrián Okša
, Jordi Comas

Line M T J Heylen, Mathilde Lassalle, Sara Hernandez Ramirez, Shalini Santhakumaran, Nurhan Seyahi, Anders Åsberg, Laurent E Weekers, José M Muñoz-Terol, Sara Trujillo-Alemán, Fatime Memeti Smaili, Mai Ots-Rosenberg, Olafur S Indridason, Kirill S Komissarov, Marc A G J Ten Dam, Maria Stendahl, Ana A Galvão, Alberto Ortiz, Vianda S Stel, Anneke Kramer

Department of Internal Diseases

Research output: Contribution to journal › Review article › peer-review

2 Citations (Scopus)

1 Downloads (Pure)

Abstract

The European Renal Association (ERA) Registry collects data on patients with kidney failure receiving kidney replacement therapy (KRT). This paper presents a summary of the ERA Registry Annual Report 2023, and focuses specifically on comparisons by age. The complete ERA Registry Annual Report 2023 is available in the Supplementary information. For 2023, data were collected from 34 countries in Europe and countries bordering the Mediterranean Sea. Using these data, incidence and prevalence of KRT, kidney transplantation rates, survival probabilities, and expected remaining lifetimes were calculated. In 2023, the ERA Registry covered 519 million people in the participating countries. The incidence of KRT was 151 per million population (pmp). Among incident patients, 29% were aged ≥75 years, 64% were male, and the most common primary renal disease (PRD) was diabetes mellitus (22%). Most patients (83%) started KRT with haemodialysis (HD), 11% started with peritoneal dialysis (PD), and 6% underwent pre-emptive kidney transplantation. On 31 December 2023, the prevalence of KRT was 1101 pmp. Among prevalent patients, 24% were aged ≥75 years, 62% were male, and the most common PRD was of miscellaneous origin (18%). Moreover, 56% of prevalent patients received HD, 5% received PD, and 39% were living with a functioning graft. In 2023, the kidney transplantation rate was 43 pmp, with 69% of kidneys coming from deceased donors. For patients starting KRT between 2014 and 2018, 5-year survival probability was 51%. The proportions of incident and prevalent patients aged ≥75 varied considerably across European countries. In addition, incident patients aged ≥75 were more often male, and had more often hypertension as PRD compared with younger patients. Only 1% of incident patients aged ≥75 received a pre-emptive kidney transplant, while among prevalent patients of the same age, 22% was living with a functioning graft.

Original language	English
Article number	sfag036
Journal	Clinical Kidney Journal
Volume	19
Issue number	5
DOIs	https://doi.org/10.1093/ckj/sfag036
Publication status	Published - May 2026

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords*

dialysis
patient survival
kidney transplantation
graft survival
kidney failure

Field of Science*

3.2 Clinical medicine

Publication Type*

1.1. Scientific article indexed in Web of Science and/or Scopus database

Access to Document

10.1093/ckj/sfag036Licence: CC BY

The ERA Registry Annual Report 2023Final published version, 4.85 MBLicence: CC BY

Cite this

Hoekstra, M. W. F., Boenink, R., Bonthuis, M., Boerstra, B. A., Astley, M. E., Montez de Sousa, I. R., Gjorgjievski, N., Resic, H., Mitsides, N., Hommel, K., Guidotti, R., Marín Sánchez, I., Slon-Roblero, M. F., Artamendi, M., Beckerman, P., Buchwinkler, L., Gellert, R., Kuzema, V., Okša, A., ... Kramer, A. (2026). The ERA Registry Annual Report 2023: epidemiology of kidney replacement therapy in Europe, with a focus on age comparisons. Clinical Kidney Journal, 19(5), Article sfag036. https://doi.org/10.1093/ckj/sfag036

@article{1db1d68a91da4c948ae7c4c32799683c,

title = "The ERA Registry Annual Report 2023: epidemiology of kidney replacement therapy in Europe, with a focus on age comparisons",

abstract = "The European Renal Association (ERA) Registry collects data on patients with kidney failure receiving kidney replacement therapy (KRT). This paper presents a summary of the ERA Registry Annual Report 2023, and focuses specifically on comparisons by age. The complete ERA Registry Annual Report 2023 is available in the Supplementary information. For 2023, data were collected from 34 countries in Europe and countries bordering the Mediterranean Sea. Using these data, incidence and prevalence of KRT, kidney transplantation rates, survival probabilities, and expected remaining lifetimes were calculated. In 2023, the ERA Registry covered 519 million people in the participating countries. The incidence of KRT was 151 per million population (pmp). Among incident patients, 29\% were aged ≥75 years, 64\% were male, and the most common primary renal disease (PRD) was diabetes mellitus (22\%). Most patients (83\%) started KRT with haemodialysis (HD), 11\% started with peritoneal dialysis (PD), and 6\% underwent pre-emptive kidney transplantation. On 31 December 2023, the prevalence of KRT was 1101 pmp. Among prevalent patients, 24\% were aged ≥75 years, 62\% were male, and the most common PRD was of miscellaneous origin (18\%). Moreover, 56\% of prevalent patients received HD, 5\% received PD, and 39\% were living with a functioning graft. In 2023, the kidney transplantation rate was 43 pmp, with 69\% of kidneys coming from deceased donors. For patients starting KRT between 2014 and 2018, 5-year survival probability was 51\%. The proportions of incident and prevalent patients aged ≥75 varied considerably across European countries. In addition, incident patients aged ≥75 were more often male, and had more often hypertension as PRD compared with younger patients. Only 1\% of incident patients aged ≥75 received a pre-emptive kidney transplant, while among prevalent patients of the same age, 22\% was living with a functioning graft.",

keywords = "dialysis, patient survival, kidney transplantation, graft survival, kidney failure",

author = "Hoekstra, \{Marin W F\} and Rianne Boenink and Marjolein Bonthuis and Boerstra, \{Brittany A\} and Astley, \{Megan E\} and \{Montez de Sousa\}, \{Iris R\} and Nikola Gjorgjievski and Halima Resic and Nicos Mitsides and Kristine Hommel and Rebecca Guidotti and \{Mar{\'i}n S{\'a}nchez\}, Inmaculada and Slon-Roblero, \{Mar{\'i}a F\} and Marta Artamendi and Pazit Beckerman and Lukas Buchwinkler and Ryszard Gellert and Viktorija Kuzema and Adri{\'a}n Ok{\v s}a and Jordi Comas and Heylen, \{Line M T J\} and Mathilde Lassalle and \{Hernandez Ramirez\}, Sara and Shalini Santhakumaran and Nurhan Seyahi and Anders {\AA}sberg and Weekers, \{Laurent E\} and Mu{\~n}oz-Terol, \{Jos{\'e} M\} and Sara Trujillo-Alem{\'a}n and \{Memeti Smaili\}, Fatime and Mai Ots-Rosenberg and Indridason, \{Olafur S\} and Komissarov, \{Kirill S\} and \{Ten Dam\}, \{Marc A G J\} and Maria Stendahl and Galv{\~a}o, \{Ana A\} and Alberto Ortiz and Stel, \{Vianda S\} and Anneke Kramer",

note = "{\textcopyright} The Author(s) 2026. Published by Oxford University Press on behalf of the ERA.",

year = "2026",

month = may,

doi = "10.1093/ckj/sfag036",

language = "English",

volume = "19",

journal = "Clinical Kidney Journal",

issn = "2048-8505",

publisher = "Oxford University Press",

number = "5",

}

Hoekstra, MWF, Boenink, R, Bonthuis, M, Boerstra, BA, Astley, ME, Montez de Sousa, IR, Gjorgjievski, N, Resic, H, Mitsides, N, Hommel, K, Guidotti, R, Marín Sánchez, I, Slon-Roblero, MF, Artamendi, M, Beckerman, P, Buchwinkler, L, Gellert, R, Kuzema, V, Okša, A, Comas, J, Heylen, LMTJ, Lassalle, M, Hernandez Ramirez, S, Santhakumaran, S, Seyahi, N, Åsberg, A, Weekers, LE, Muñoz-Terol, JM, Trujillo-Alemán, S, Memeti Smaili, F, Ots-Rosenberg, M, Indridason, OS, Komissarov, KS, Ten Dam, MAGJ, Stendahl, M, Galvão, AA, Ortiz, A, Stel, VS & Kramer, A 2026, 'The ERA Registry Annual Report 2023: epidemiology of kidney replacement therapy in Europe, with a focus on age comparisons', Clinical Kidney Journal, vol. 19, no. 5, sfag036. https://doi.org/10.1093/ckj/sfag036

TY - JOUR

T1 - The ERA Registry Annual Report 2023

T2 - epidemiology of kidney replacement therapy in Europe, with a focus on age comparisons

AU - Hoekstra, Marin W F

AU - Boenink, Rianne

AU - Bonthuis, Marjolein

AU - Boerstra, Brittany A

AU - Astley, Megan E

AU - Montez de Sousa, Iris R

AU - Gjorgjievski, Nikola

AU - Resic, Halima

AU - Mitsides, Nicos

AU - Hommel, Kristine

AU - Guidotti, Rebecca

AU - Marín Sánchez, Inmaculada

AU - Slon-Roblero, María F

AU - Artamendi, Marta

AU - Beckerman, Pazit

AU - Buchwinkler, Lukas

AU - Gellert, Ryszard

AU - Kuzema, Viktorija

AU - Okša, Adrián

AU - Comas, Jordi

AU - Heylen, Line M T J

AU - Lassalle, Mathilde

AU - Hernandez Ramirez, Sara

AU - Santhakumaran, Shalini

AU - Seyahi, Nurhan

AU - Åsberg, Anders

AU - Weekers, Laurent E

AU - Muñoz-Terol, José M

AU - Trujillo-Alemán, Sara

AU - Memeti Smaili, Fatime

AU - Ots-Rosenberg, Mai

AU - Indridason, Olafur S

AU - Komissarov, Kirill S

AU - Ten Dam, Marc A G J

AU - Stendahl, Maria

AU - Galvão, Ana A

AU - Ortiz, Alberto

AU - Stel, Vianda S

AU - Kramer, Anneke

PY - 2026/5

Y1 - 2026/5

N2 - The European Renal Association (ERA) Registry collects data on patients with kidney failure receiving kidney replacement therapy (KRT). This paper presents a summary of the ERA Registry Annual Report 2023, and focuses specifically on comparisons by age. The complete ERA Registry Annual Report 2023 is available in the Supplementary information. For 2023, data were collected from 34 countries in Europe and countries bordering the Mediterranean Sea. Using these data, incidence and prevalence of KRT, kidney transplantation rates, survival probabilities, and expected remaining lifetimes were calculated. In 2023, the ERA Registry covered 519 million people in the participating countries. The incidence of KRT was 151 per million population (pmp). Among incident patients, 29% were aged ≥75 years, 64% were male, and the most common primary renal disease (PRD) was diabetes mellitus (22%). Most patients (83%) started KRT with haemodialysis (HD), 11% started with peritoneal dialysis (PD), and 6% underwent pre-emptive kidney transplantation. On 31 December 2023, the prevalence of KRT was 1101 pmp. Among prevalent patients, 24% were aged ≥75 years, 62% were male, and the most common PRD was of miscellaneous origin (18%). Moreover, 56% of prevalent patients received HD, 5% received PD, and 39% were living with a functioning graft. In 2023, the kidney transplantation rate was 43 pmp, with 69% of kidneys coming from deceased donors. For patients starting KRT between 2014 and 2018, 5-year survival probability was 51%. The proportions of incident and prevalent patients aged ≥75 varied considerably across European countries. In addition, incident patients aged ≥75 were more often male, and had more often hypertension as PRD compared with younger patients. Only 1% of incident patients aged ≥75 received a pre-emptive kidney transplant, while among prevalent patients of the same age, 22% was living with a functioning graft.

AB - The European Renal Association (ERA) Registry collects data on patients with kidney failure receiving kidney replacement therapy (KRT). This paper presents a summary of the ERA Registry Annual Report 2023, and focuses specifically on comparisons by age. The complete ERA Registry Annual Report 2023 is available in the Supplementary information. For 2023, data were collected from 34 countries in Europe and countries bordering the Mediterranean Sea. Using these data, incidence and prevalence of KRT, kidney transplantation rates, survival probabilities, and expected remaining lifetimes were calculated. In 2023, the ERA Registry covered 519 million people in the participating countries. The incidence of KRT was 151 per million population (pmp). Among incident patients, 29% were aged ≥75 years, 64% were male, and the most common primary renal disease (PRD) was diabetes mellitus (22%). Most patients (83%) started KRT with haemodialysis (HD), 11% started with peritoneal dialysis (PD), and 6% underwent pre-emptive kidney transplantation. On 31 December 2023, the prevalence of KRT was 1101 pmp. Among prevalent patients, 24% were aged ≥75 years, 62% were male, and the most common PRD was of miscellaneous origin (18%). Moreover, 56% of prevalent patients received HD, 5% received PD, and 39% were living with a functioning graft. In 2023, the kidney transplantation rate was 43 pmp, with 69% of kidneys coming from deceased donors. For patients starting KRT between 2014 and 2018, 5-year survival probability was 51%. The proportions of incident and prevalent patients aged ≥75 varied considerably across European countries. In addition, incident patients aged ≥75 were more often male, and had more often hypertension as PRD compared with younger patients. Only 1% of incident patients aged ≥75 received a pre-emptive kidney transplant, while among prevalent patients of the same age, 22% was living with a functioning graft.

KW - dialysis

KW - patient survival

KW - kidney transplantation

KW - graft survival

KW - kidney failure

UR - https://www-webofscience-com.db.rsu.lv/wos/alldb/full-record/WOS:001757069400001

UR - https://pmc.ncbi.nlm.nih.gov/articles/PMC13146735/

UR - https://www.scopus.com/pages/publications/105037926017

U2 - 10.1093/ckj/sfag036

DO - 10.1093/ckj/sfag036

M3 - Review article

C2 - 42100711

SN - 2048-8505

VL - 19

JO - Clinical Kidney Journal

JF - Clinical Kidney Journal

IS - 5

M1 - sfag036

ER -

The ERA Registry Annual Report 2023: epidemiology of kidney replacement therapy in Europe, with a focus on age comparisons

Abstract

UN SDGs

Keywords*

Field of Science*

Publication Type*

Access to Document

Other files and links

Fingerprint

Cite this